Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of tetrahydrocannabinol on ocular hemodynamics in primary open angle glaucoma (Phase II)
2019-003089-42Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol in open-angle glaucoma (OAG) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Optic nerve head blood flow. Started Nov 2019; status: completed.
02
Drugs
dronabinol
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2019-003089-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003089-42.